DOJ's $2.28M contract for urinalysis drug testing cups awarded to PHAMATECH, INCORPORATED
Contract Overview
Contract Amount: $2,280 ($2.3K)
Contractor: Phamatech, Incorporated
Awarding Agency: Department of Justice
Start Date: 2026-04-10
End Date: 2026-04-10
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: RP# 0063-26 PHAMATECH URINALYSES DRUG TESTING CUPS
Place of Performance
Location: SAN DIEGO, SAN DIEGO County, CALIFORNIA, 92128
Plain-Language Summary
Department of Justice obligated $2,280 to PHAMATECH, INCORPORATED for work described as: RP# 0063-26 PHAMATECH URINALYSES DRUG TESTING CUPS Key points: 1. Contract awarded through full and open competition, suggesting a competitive pricing environment. 2. The contract is a BPA Call, indicating it's part of a larger pre-negotiated agreement. 3. The fixed-price contract type helps mitigate cost overrun risks for the government. 4. The duration of the contract is one year, allowing for regular reassessment of needs. 5. The specific product is analytical laboratory instrument manufacturing, a niche but essential service. 6. The award amount is relatively modest, suggesting a focused scope of work.
Value Assessment
Rating: good
The contract value of $2.28 million for urinalysis drug testing cups appears reasonable given the nature of the product and the agency. Without specific per-unit cost data or comparable contract benchmarks, a precise value-for-money assessment is challenging. However, the use of a Firm Fixed Price contract suggests that the pricing was determined upfront and is intended to be cost-effective for the government. The award to a single vendor, PHAMATECH, INCORPORATED, under a BPA Call implies that pricing may have been established through a prior competitive process under the broader BPA.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
This contract was awarded under full and open competition, which is the preferred method for federal procurements. This process typically involves soliciting offers from all responsible sources and providing full and open competition. The number of bidders is not specified, but the method itself suggests that multiple vendors had the opportunity to compete. This level of competition is generally expected to lead to more favorable pricing and better quality products or services for the government.
Taxpayer Impact: Full and open competition maximizes the potential for the government to obtain the best value for taxpayer dollars by encouraging a wide range of offers and driving down prices through market forces.
Public Impact
The Federal Prison System / Bureau of Prisons benefits from a reliable supply of essential drug testing cups. This contract ensures the availability of analytical laboratory instruments for drug testing within correctional facilities. The geographic impact is primarily within the United States, supporting federal correctional operations. The contract supports the workforce involved in the manufacturing and distribution of these testing supplies.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Lack of specific performance metrics or quality assurance details in the provided data.
- Potential for supply chain disruptions affecting the availability of critical testing supplies.
- Dependence on a single contractor for a specific type of essential testing equipment.
Positive Signals
- Awarded through full and open competition, indicating a competitive bidding process.
- Firm Fixed Price contract type helps control costs and budget predictability.
- The contract is part of a BPA Call, suggesting a pre-vetted and potentially cost-effective arrangement.
- The contractor, PHAMATECH, INCORPORATED, is supplying a necessary product for correctional facility operations.
Sector Analysis
The market for analytical laboratory instruments, including diagnostic and testing supplies like urinalysis cups, is a specialized segment within the broader healthcare and scientific equipment industry. This contract falls under the 'Analytical Laboratory Instrument Manufacturing' North American Industry Classification System (NAICS) code. Spending in this sector is driven by the needs of government agencies, research institutions, and healthcare providers for diagnostic tools and testing capabilities. Benchmarks for similar contracts would typically involve comparing unit costs for specific types of testing kits and the overall value of supply agreements for correctional or healthcare facilities.
Small Business Impact
The provided data indicates that small business participation (ss: false, sb: false) was not a specific set-aside requirement for this contract. Therefore, there are no direct implications for small business set-asides. However, the prime contractor, PHAMATECH, INCORPORATED, may engage small businesses as subcontractors, though this information is not detailed here. The absence of a small business focus in the primary award suggests that the competition was geared towards larger or more specialized firms capable of meeting the contract's technical requirements.
Oversight & Accountability
Oversight for this contract would typically fall under the purview of the Department of Justice's procurement and program management offices. As it is a BPA Call, oversight may also be linked to the administration of the parent Blanket Purchase Agreement. Transparency is generally maintained through contract databases like FPDS. Inspector General jurisdiction would apply in cases of suspected fraud, waste, or abuse related to the contract's execution.
Related Government Programs
- Department of Justice Drug Enforcement Programs
- Federal Bureau of Prisons Healthcare Services
- Substance Abuse and Mental Health Services Administration (SAMHSA) Grants
- Department of Health and Human Services (HHS) Laboratory Services
Risk Flags
- Potential for supply chain disruption
- Dependence on a single supplier for critical items
- Need for ongoing quality assurance monitoring
Tags
department-of-justice, federal-prison-system, bureau-of-prisons, pharmaceuticals-and-medical-supplies, analytical-laboratory-instrument-manufacturing, firm-fixed-price, full-and-open-competition, bpa-call, drug-testing-supplies, correctional-facilities, california, phamatech-incorporated
Frequently Asked Questions
What is this federal contract paying for?
Department of Justice awarded $2,280 to PHAMATECH, INCORPORATED. RP# 0063-26 PHAMATECH URINALYSES DRUG TESTING CUPS
Who is the contractor on this award?
The obligated recipient is PHAMATECH, INCORPORATED.
Which agency awarded this contract?
Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).
What is the total obligated amount?
The obligated amount is $2,280.
What is the period of performance?
Start: 2026-04-10. End: 2026-04-10.
What is the historical spending pattern for urinalysis drug testing cups by the Department of Justice?
Analyzing historical spending for urinalysis drug testing cups by the Department of Justice (DOJ) requires accessing detailed procurement data over several fiscal years. While this specific contract is for $2.28 million, understanding the DOJ's broader spending trends in this category would involve looking at awards made by various components, including the Federal Prison System (FPS) and the Bureau of Prisons (BOP). Factors influencing historical spending include changes in drug interdiction policies, inmate population size, and the adoption of new testing technologies. A trend analysis might reveal whether spending has been consistent, increasing, or decreasing, and whether PHAMATECH, INCORPORATED has been a consistent supplier or if other vendors have previously held significant contracts in this area. Without access to a comprehensive historical database filtered for this specific product category across all DOJ entities, a precise historical spending pattern cannot be definitively established from this single award notice.
How does the unit cost of these testing cups compare to similar contracts or market rates?
A direct comparison of the unit cost for PHAMATECH's urinalysis drug testing cups to similar contracts or market rates is not possible with the information provided. The contract value is $2.28 million, but the quantity of cups or the price per cup is not specified. To perform such a benchmark, one would need to know the total number of cups procured under this contract and then divide the total contract value by that quantity. Subsequently, this per-unit cost would need to be compared against publicly available pricing data for similar drug testing kits from other manufacturers or against historical awards for comparable items made by other federal agencies or state/local governments. The fact that this is a BPA Call suggests that pricing may have been established under a broader, potentially competitive, agreement, which could offer some indication of its market competitiveness, but without the specific unit price, a definitive comparison remains elusive.
What are the key performance indicators (KPIs) for this contract, and how is PHAMATECH's performance being measured?
The provided data does not explicitly detail the Key Performance Indicators (KPIs) or the specific performance measurement criteria for this contract with PHAMATECH, INCORPORATED. Typically, for supply contracts of this nature, KPIs would focus on aspects such as on-time delivery rates, order fill rates, product quality (e.g., accuracy of tests, absence of defects), and responsiveness to inquiries or issues. Performance is usually monitored by the Contracting Officer's Representative (COR) or the contract administration team within the agency. PHAMATECH's adherence to delivery schedules and the quality of the urinalysis cups would be critical factors. The contract's success would be evaluated based on whether it consistently meets the agency's needs for these essential testing supplies without disruption.
What is PHAMATECH, INCORPORATED's track record with federal contracts, particularly with the Department of Justice?
PHAMATECH, INCORPORATED has a track record of receiving federal contracts, as evidenced by this award from the Department of Justice (DOJ). To assess their broader track record, a review of federal procurement databases (like FPDS) would be necessary to identify all contracts awarded to the company across various agencies and over time. This would reveal the types of goods or services they have provided, the contract values, and their performance history, including any awards or disputes. Their specific history with the DOJ would indicate if they are a frequent or sole supplier for certain items, or if they have successfully competed for various types of procurements. A positive track record, characterized by successful past performance and compliance, generally increases confidence in a contractor's ability to fulfill current obligations effectively.
What are the potential risks associated with this contract, and what mitigation strategies are in place?
Potential risks associated with this contract include supply chain disruptions that could impact the availability of urinalysis drug testing cups, potential quality control issues with the manufactured product, and the risk of price increases if the contract were to be re-competed under less favorable market conditions. Given that this is a Firm Fixed Price contract awarded under full and open competition, some risks are inherently managed. Mitigation strategies often involve robust contract administration, including monitoring delivery schedules and product quality, maintaining open communication channels with the contractor, and having contingency plans for alternative suppliers if necessary. The relatively short one-year duration also allows for periodic reassessment of risks and performance.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Solicitation ID: 15BNAS24Q00000006
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 15175 INNOVATION DR, SAN DIEGO, CA, 92128
Business Categories: Asian Pacific American Owned Business, Category Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Minority Owned Business, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $2,280
Exercised Options: $2,280
Current Obligation: $2,280
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: 15BNAS24A00000044
IDV Type: BPA
Timeline
Start Date: 2026-04-10
Current End Date: 2026-04-10
Potential End Date: 2026-04-10 00:00:00
Last Modified: 2026-04-02
More Contracts from Phamatech, Incorporated
- National BPA 15bnas24a00000044. Field Notice 0003. Option Year 1 October 1, 2024 Through September 30, 2025 — $20.6K (Department of Justice)
- FY26 E3 Phamatech Drug Testing Supplies OCT 26 — $16.9K (Department of Justice)
- Inmate Urinalysis On-Site Test CUP and Laboratory Services — $16.9K (Department of Justice)
- Phamatech Inmate Urinalysis Cups & Testing BPA 15bnas24a00000044 — $15.8K (Department of Justice)
- FY26 - Inmate UA LAB Testing FCI I OAK-0335 FCI II OAD-0330 — $11.9K (Department of Justice)
Other Department of Justice Contracts
- Contractor Owned and Operated Existing Correctional Facility for Approximately 3,500 LOW Security Male Inmates — $794.5M (Cornell Companies, Inc.)
- Detention Services - SAN Diego — $776.9M (THE GEO Group, Inc.)
- CO: Telly Renfroe Award of NEW Task Order Base Year Initial Funding — $616.4M (AT&T Enterprises, LLC)
- TAS 151060 - Services for the Management and Operation of a Contractor-Owned, Contractor-Operated, Correctional Facility for 2,567 Beds in Adams County, Mississippi — $574.3M (Corecivic, Inc.)
- Provide Services for the Management and Operation of a Correctional Facility in Accordance With Rfp-Pcc-0014 — $568.9M (Cornell Companies, Inc.)